BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4076236)

  • 1. Technetium thiodiglycollic acid (99mTc-TDG). A new radiopharmaceutical with the potential for the assessment of renal function.
    Nowotnik DP; Pickett RD; Allen CD
    Eur J Nucl Med; 1985; 11(8):285-9. PubMed ID: 4076236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99Tcm-TDG renography with deconvolution analysis: a comparative study with 99Tcm-DTPA and 123I-hippuran.
    Bevis CR; Lawson RS; Shields RA; Testa HJ
    Nucl Med Commun; 1984 Aug; 5(8):513-7. PubMed ID: 6398412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m complex of N-(2-pyridylmethyl)iminodiacetic acid as a new renal radiopharmaceutical.
    Karube Y; Iwamoto K; Takata J
    Ann Nucl Med; 1999 Apr; 13(2):127-32. PubMed ID: 10355959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tcm-p-aminohippuric acid as a new renal agent.
    Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
    Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cyclosporine nephrotoxicity in rats with various renal radioactive agents.
    McAfee JG; Thomas FD; Subramanian G; Roskopf M; Hellwig B
    J Nucl Med; 1988 Sep; 29(9):1577-81. PubMed ID: 2842472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study.
    Perrone RD; Steinman TI; Beck GJ; Skibinski CI; Royal HD; Lawlor M; Hunsicker LG
    Am J Kidney Dis; 1990 Sep; 16(3):224-35. PubMed ID: 2205098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and quality control of 99mTc-calciumgluconate.
    Zmbova B; Djokić D; Jovanović V; Tadzer I; Memedović T
    Nuklearmedizin; 1983 Jun; 22(3):166-8. PubMed ID: 6622264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
    Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
    J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
    Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
    J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR; Kasina S; Eshima D; Johnson DL
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
    Trejtnar F; Laznicek M; Laznickova A; Mather SJ
    J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake.
    de Lange MJ; Piers DA; Kosterink JG; van Luijk WH; Meijer S; de Zeeuw D; van der Hem GK
    J Nucl Med; 1989 Jul; 30(7):1219-23. PubMed ID: 2544699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new radiopharmaceutical: 99mTc DMP for renal scanning.
    Tanaka A; Machida T; Miki M; Shimada T
    Eur J Nucl Med; 1983; 8(7):317-20. PubMed ID: 6884382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative renal scintigraphic determination of the glomerular filtration rate in cats with normal and abnormal kidney function, using 99mTc-diethylenetriaminepentaacetic acid.
    Uribe D; Krawiec DR; Twardock AR; Gelberg HB
    Am J Vet Res; 1992 Jul; 53(7):1101-7. PubMed ID: 1497177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the biodistribution and in vivo biochemistry of 99mTc-cysteine and 99/99mTc-cysteine complexes--a potential renal imaging agent.
    Wang AY; Liu RS
    Nucl Med Biol; 1995 Oct; 22(7):937-42. PubMed ID: 8547892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.
    He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT
    Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, quality control and application of 99mTc-gluco-ene-diolate for renal scanning.
    Shafiq YF; Al-Janabi MA
    Nuklearmedizin; 1985 Apr; 24(2):93-5. PubMed ID: 4022788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-labelled compounds prepared with molybdenum III as reducing agent.
    Vilcek S; Machán V; Kalincák M
    Int J Appl Radiat Isot; 1984 Mar; 35(3):228-30. PubMed ID: 6425226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.